Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schiff Nutrition Enlists Airborne For Sortie Into Immune Support

This article was originally published in The Tan Sheet

Executive Summary

The $150 million price represents more than twice Airborne’s approximately $70 million in annual net revenues for supplements marketed to strengthen immune support. The acquisition from GF Capital follows Pfizer’s recent foray into the immune support space by buying the maker of Emergen-C products.

Advertisement

Related Content

Biopharma Dealmaking Quarterly Statistics, Q4 2012
Bayer’s Schiff Nutrition Deal Expands Supplement Portfolio
Sales & Earnings In Brief
Brand-Boosting Schiff Nutrition Sees Upside In Top-Selling Supplements
In Brief
In Brief
Schiff Nutrition Gains Probiotics Ingredient, Brands From Ganeden
Acquisition Primes Airborne For Claims Overhaul

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS105673

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel